Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration
- PMID: 3991617
Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration
Similar articles
-
Methods of evaluating the alleged teratogenicity of environmental agents.Prog Clin Biol Res. 1985;163C:191-5. Prog Clin Biol Res. 1985. PMID: 3991621 No abstract available.
-
Potential subversion of pregnancy prevention program in the managed care setting.Arch Dermatol. 1997 Feb;133(2):243-4. Arch Dermatol. 1997. PMID: 9041846 No abstract available.
-
Drug and other hazards to the fetus and newborn.Prog Clin Biol Res. 1980;36:67-72. Prog Clin Biol Res. 1980. PMID: 7403181 No abstract available.
-
The complexities of solving the problem of human malformations.Clin Perinatol. 1986 Sep;13(3):491-503. Clin Perinatol. 1986. PMID: 3533363 Review.
-
Drugs in pregnancy and their effects on pre- and postnatal development.Res Publ Assoc Res Nerv Ment Dis. 1973;51:233-43. Res Publ Assoc Res Nerv Ment Dis. 1973. PMID: 4590403 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical